PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Positive results from hVIVO study of Cidara flu candidate

The study demonstrated a reduction in viral replication in the upper respiratory tract as well as influenza infection. hVIVO – a company focused on testing global...
Continue Reading →
News

ABPI’s Patient Advisory Council boosted by new leaders

Five vital new appointments were made to the regulator’s insight, perspective and advice group. The Association of the British Pharmaceutical Industry (ABPI) has ...
Continue Reading →
News

Janssen’s Rybrevant yields positive data

Results from the trial showed a long-term response among specific lung cancer populations. The Janssen Pharmaceutical Companies of Johnson & Johnson has annou...
Continue Reading →
News

Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors

The Waters™ Alliance™ iS High-Performance Liquid Chromatography (HPLC) System brings a new level of simplicity and instrument intelligence to QC analyses, helping l...
Continue Reading →
News

iOnctura’s roginolisib awarded Innovation Passport

MHRA designation involves entry into innovative licensing and access pathways. iOnctura – a company developing treatments for patients with cancer – has announced...
Continue Reading →
News

EnteroBiotix begins phase 2 study of candidate drug EBX-102

A clinical trial involves patients with liver cirrhosis and hepatic encephalopathy. EnteroBiotix Limited – a company concentrating on microbiome therapeutics – ha...
Continue Reading →
News

FDA oks Pharming rare immune disorder drug

The U.S. FDA has approved Pharming Group's PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome (APDS) in adult and pediatric pati...
Continue Reading →
News

SolasCure announces pivotal financing round for hydrogel

The company is developing a therapy containing an enzyme cloned from medical maggots. SolasCure – a company developing a hydrogel – has announced the completion o...
Continue Reading →
News

CSL’s Hemgenix receives MHRA authorisation

Treatment is the only single infusion gene therapy for the treatment of severe haemophilia B CSL has announced that the UK Medicines and Healthcare products Regul...
Continue Reading →
News

CPHI Pharma Awards open to global innovators, scientists, entrepreneurs and social leaders

New categories launched with awards for Accelerating Innovation, Start-ups and being at the Heart of Pharma The 20th-anniversary edition of the CPHI Pharma Awards...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026